EXAGEN INC.
EXAGEN INC. is a registered legal entity registered in United States under 3396686, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 18 May 2011 and lists its registered address as VISTA, United States. 5 shareholders are on record for EXAGEN INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 22 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Shareholders of EXAGEN INC.
Five shareholders are currently on record for EXAGEN INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 9.7% — the largest recorded stake — followed by Invesco Exch-Trd Fd. TRT II-Invesco Dorsey Wright SmallCap Momentum ET at 8.8%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Data availability
The register reports 6 shareholders in total, though only the top 5 by holding are shown in this view.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 9.7% | California Secretary of State — bizfile Online | |
| Invesco Exch-Trd Fd. TRT II-Invesco Dorsey Wright SmallCap Momentum ET | 8.8% | California Secretary of State — bizfile Online | |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.9% | California Secretary of State — bizfile Online | |
| Wexford Capital LP | 5.5% | California Secretary of State — bizfile Online | |
| iShares Trust-iShares Micro-Cap ETF | 0.4% | California Secretary of State — bizfile Online |
Officers
5
Directors and officers of EXAGEN INC.
The Chief Executive Officer of EXAGEN INC. currently on record is John Aballi; five officers are currently on record for EXAGEN INC., filed with California Secretary of State — bizfile Online. Management authority at EXAGEN INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Data availability
The register reports 14 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns EXAGEN INC.?
Five shareholders are currently on record for EXAGEN INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 9.7% — the largest recorded stake — followed by Invesco Exch-Trd Fd. TRT II-Invesco Dorsey Wright SmallCap Momentum ET at 8.8%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is EXAGEN INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for EXAGEN INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does EXAGEN INC. have on record?
5 shareholders are shown on record for EXAGEN INC.. The register reports 6 in total; only the top 5 by holding are shown here.
What is EXAGEN INC.'s company registration number?
EXAGEN INC.'s registration number is 3396686, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is EXAGEN INC. still an active company?
EXAGEN INC.'s status on California Secretary of State — bizfile Online is listed as active.
When was EXAGEN INC. incorporated?
EXAGEN INC. was incorporated on 18 May 2011, according to California Secretary of State — bizfile Online.
What is EXAGEN INC.'s registered address?
The registered address on file for EXAGEN INC. is VISTA, United States.
Who are the officers/directors of EXAGEN INC.?
The Chief Executive Officer of EXAGEN INC. currently on record is John Aballi; five officers are currently on record for EXAGEN INC., filed with California Secretary of State — bizfile Online. Management authority at EXAGEN INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to EXAGEN INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to EXAGEN INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access EXAGEN INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like EXAGEN INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 22 September 2026.